 |
PDBsum entry 1nmc
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Complex (single-chain antibody/antigen)
|
PDB id
|
|
|
|
1nmc
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
388 a.a.
|
 |
|
|
|
|
|
|
|
122 a.a.
|
 |
|
|
|
|
|
|
|
109 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Complex (single-chain antibody/antigen)
|
 |
|
Title:
|
 |
Complex between nc10 anti-influenza virus neuraminidase single chain antibody with a 15 residue linker and influenza virus neuraminidase
|
|
Structure:
|
 |
Neuraminidase. Chain: n, a. Fragment: residues 82 - 468. Engineered: yes. Single chain antibody. Chain: h, b. Fragment: vh and vl domains of anti-neuraminidase antibody nc10 covalently joined by a fifteen residue polypeptide linker. Engineered: yes.
|
|
Source:
|
 |
Influenza a virus. Organism_taxid: 11320. Strain: n9. Variant: a/tern/australia/g70c/75. Expressed in: gallus gallus. Expression_system_taxid: 9031. Expression_system_cell: egg. Mus musculus. House mouse.
|
|
Biol. unit:
|
 |
Hexamer (from
)
|
|
Resolution:
|
 |
|
2.50Å
|
R-factor:
|
0.220
|
R-free:
|
0.260
|
|
|
Authors:
|
 |
R.L.Malby,A.J.Mccoy,A.A.Kortt,P.J.Hudson,P.M.Colman
|
Key ref:
|
 |
R.L.Malby
et al.
(1998).
Three-dimensional structures of single-chain Fv-neuraminidase complexes.
J Mol Biol,
279,
901-910.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
21-Dec-97
|
Release date:
|
23-Sep-98
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P03472
(NRAM_I75A5) -
Neuraminidase from Influenza A virus (strain A/Tern/Australia/G70C/1975 H11N9)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
470 a.a.
388 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains N, A:
E.C.3.2.1.18
- exo-alpha-sialidase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Hydrolysis of alpha-(2->3)-, alpha-(2->6)-, alpha-(2->8)-glycosidic linkages of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid and synthetic substrates.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
279:901-910
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
Three-dimensional structures of single-chain Fv-neuraminidase complexes.
|
|
R.L.Malby,
A.J.McCoy,
A.A.Kortt,
P.J.Hudson,
P.M.Colman.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The structure of the complex between a recombinant single-chain Fv construct of
antibody NC10 with a five-residue peptide linker between VH and VL (termed
scFv(5)), and its antigen, tetrameric neuraminidase from influenza virus (NA),
has been determined and refined at 2.5 A resolution. The antibody-antigen
binding interface is very similar to that of a similar NC10 scFv-NA complex in
which the scFv has a 15-residue peptide linker (scFv(15)), and the NC10 Fab-NA
complex. However, scFv(5) and scFv(15) have different stoichiometries in
solution. While scFv(15) is predominantly monomeric in solution, scFv(5) forms
dimers exclusively, because the five-residue linker is not long enough to permit
VH and VL domains from the same polypeptide associating and forming an
antigen-binding site. Upon forming a complex with NA, scFv(15) forms a
approximately 300 kDa complex corresponding to one NA tetramer binding four
scFv(15) monomers, while scFv(5) forms a approximately 590 kDa complex,
corresponding to two NA tetramers crosslinked by four bivalent scFv(5) dimers.
However, the dimeric scFv(5) in the scFv(5)-NA crystals does not crosslink NA
tetramers, and modelling studies indicate that it is not possible to pack four
dimeric and simultaneously bivalent scFvs between the NA tetramers with only a
five-residue linker between VH and VL. The inability arises from the exacting
requirement to orient the two antigen-binding surfaces to bind the tetrameric NA
antigen while avoiding steric clashes with NC10 scFv(5) dimers bound to other
sites on the NA tetramer. The utility of bivalent or bifunctional scFvs with
short linkers may therefore be restricted by the steric constraints imposed by
binding multivalent antigens.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Model of the vert,
similar 590 kDa complex observed in solution studies of the NC10
scFv(5)-NA, in which the scFv(5) is dimeric and bivalent [Kortt
et al 1997]. Model is shown as a bold C^αtrace. The NA
tetramers (green and purple) are crosslinked by scFv(5)
molecules. The Fv domain bound to the green NA is shown with
V[L]yellow and V[H]orange, while the Fv domain bound to the
purple NA is shown with V[L]light blue and V[H]dark blue. The
scFv(5) is thus shown with one V[L]yellow and the other light
blue, and one V[H]orange and the other dark-blue. The complex
has point group 422 symmetry. Drawn with MOLSCRIPT [Kraulis
1991] and RASTER3D [Bacon and Anderson 1989 and Merritt and
Murphy 1994]. (a) View with the molecular 4-fold axis vertical.
(b) View with the molecular 4-fold axis out of the page.
|
 |
Figure 3.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(1998,
279,
901-910)
copyright 1998.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
I.C.Wilkinson,
C.J.Hall,
V.Veverka,
J.Y.Shi,
F.W.Muskett,
P.E.Stephens,
R.J.Taylor,
A.J.Henry,
and
M.D.Carr
(2009).
High resolution NMR-based model for the structure of a scFv-IL-1beta complex: potential for NMR as a key tool in therapeutic antibody design and development.
|
| |
J Biol Chem,
284,
31928-31935.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.Liu,
and
D.Eisenberg
(2002).
3D domain swapping: as domains continue to swap.
|
| |
Protein Sci,
11,
1285-1299.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |
| |